Clinical Trial Update: Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

View source ↗

Summary

A recruiting clinical trial evaluating biomarkers for diagnosing lung cancer, predicting post-treatment recurrence risk, and guiding long-term surveillance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Lung Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung; Node, Adenocarcinoma of Lung | Status: RECRUITING